Abstract Details

Title Effect of Natalizumab on Relapse Outcomes in Patients with Relapsing MS Who Experience MRI Activity during Treatment

Topic MS and Related Diseases

Presentation(s) (-)

Poster/Presentation
Number 135

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
David Bates	No disclosure on file
Mohammad Ikram (Erasmus MC)	The institution of Mohammad Ikram has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BioGen Inc.
Emmanuel J. Bartholome (Erasmus Hospital - Immunology)	Emmanuel J. Bartholome has received personal compensation for serving as an employee of Indivi AG. Emmanuel J. Bartholome has received personal compensation for serving as an employee of Biogen.
Amy Pace, ScD	No disclosure on file
Robert Hyde, PhD (Biogen)	Dr. Hyde has received personal compensation for serving as an employee of Biogen International GmbH . Dr. Hyde has received stock or an ownership interest from Biogen .
Christophe Hotermans, MD, PhD (Alexion)	No disclosure on file
	No disclosure on file

��ɫ��